Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-16

Clinical Trial Update: NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis

View source ↗

Summary

A clinical trial at a national referral center is evaluating tafamidis in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tafamidis (tafamidis)

Snippet

Sponsor: Paolo Milani | Conditions: Amyloidosis, Amyloidosis Cardiac | Status: RECRUITING